MarketPulse

cardiovascular disease

5 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

BioCardia to Unveil 2025 Results, Corporate Strategy on March 24 Call

BioCardia scheduled conference call for March 24, 2026 to report full-year 2025 financial results and provide corporate update.
BCDAfinancial resultsconference call
BenzingaBenzinga··Vandana Singh

Tenaya Therapeutics Surges 31% on Alnylam Cardiovascular Research Deal

Tenaya Therapeutics surges 31% after partnering with Alnylam on cardiovascular genetic targets, securing $10M upfront and $1.13B in potential milestone payments.
TNYAALNYgene therapycardiovascular disease
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

GLP-1 Market Set to Nearly Triple to $137B by 2030 as Drug Class Expands Beyond Diabetes

GLP-1 receptor agonist market projected to surge from $51.9B in 2024 to $137.4B by 2030, driven by obesity prevalence and expanded therapeutic applications.
AMGNPFELLYNVORHHBY+1weight lossdiabetes treatment
GlobeNewswire Inc.GlobeNewswire Inc.··Seer, Inc.

Seer Showcases Proteograph Platform at US HUPO 2026 Conference

Seer presents its Proteograph platform at US HUPO 2026, showcasing proteomics research across cardiovascular, neurodegenerative, aging, and oncology applications using minimal sample volumes.
SEERproteomicsProteograph Product Suite
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Pulmonary Artery Catheter Market Projected to Expand 60% Through 2035

Pulmonary artery catheter market projected to grow from $1.23B to $1.97B by 2035, driven by rising cardiovascular disease and expanding critical care infrastructure globally.
MDTBSXEWBDXTFXmedical devicescardiovascular disease